Elite in Salpingo-Oophorectomy

Andrea F. Eisen

Toronto, ON, CA 
Elite in Salpingo-Oophorectomy
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Andrea Eisen practices in Toronto, Canada. Ms. Eisen is rated as an Elite expert by MediFind in Oophorectomy. Her top areas of expertise are Breast Cancer, Ovarian Cancer, HER-2 Positive Breast Cancer, Oophorectomy, and Mastectomy.

Her clinical research consists of co-authoring 181 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 19 articles in the study of Oophorectomy.

Gender
Female

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada
Hamilton, ON L8V5C2, Canada
Oshawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Genetics Adviser: Evaluating a Digital Decision Support Tool for Genetic Results
Genetics Adviser: Evaluating a Digital Decision Support Tool for Genetic Results
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other
Study Phase: Not Applicable
The Health Outcomes, Utility, and Costs of Returning Incidental Genomic Findings
The Health Outcomes, Utility, and Costs of Returning Incidental Genomic Findings
Enrollment Status: Active_not_recruiting
Publish Date: December 06, 2023
Intervention Type: Other
Study Phase: Not Applicable
The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population of Patients With Estrogen Receptor- Positive Early Breast Cancer With 1-3 Positive Lymph Nodes
The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population of Patients With Estrogen Receptor- Positive Early Breast Cancer With 1-3 Positive Lymph Nodes
Enrollment Status: Completed
Publish Date: October 23, 2020
Intervention Type: Other
Study Phase: Not Applicable
Randomized Controlled Trial of a Decision Aid for Incidental Genomic Findings
Randomized Controlled Trial of a Decision Aid for Incidental Genomic Findings
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 4 Less Clinical Trials

181 Total Publications

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.
Journal: Gynecologic oncology
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Eisen's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile